By Nigam Arora & Dr. Natasha Arora
With the stock market recently hitting record highs, prudent investors are looking for investment opportunities that capture profits while simultaneously minimizing risk.
Where Smart Money Is Looking
The Arora Report has released new buy zones on a cross section of ETFs that capture powerful macro themes from artificial intelligence and semiconductors to commodities to Indian equities.
Here are a few examples:
- Demand for AI continues to increase in this phase of the golden age of AI.
- There are opportunities in cyber security.
- Semiconductors are the lifeblood of the modern economy.
- There are opportunities in oil and gas field services due to President Trump’s policies.
- Trump administration policies are shaking up other commodities, creating opportunities for investors.
Why Buy Zones Matter
For nearly two decades, investors who have followed Arora buy zones have consistently grown their wealth and have done so with less risk than the broader market. These zones are determined by the ZYX Change Method, a rigorously tested framework that blends money flows, fundamental trends, sentiment shifts, and quantitative signals. When an ETF enters the Arora buy zone, the odds begin to favor high risk adjusted returns.
Timing Opportunities
Recent market swings have brought several high quality ETFs into Arora buy zones. For disciplined investors, this volatility is not a threat — it is a window of opportunity. Some positions are already actionable, while others call for patience. Scaling in within the buy zones remains one of the most effective ways to optimize risk adjusted returns.
Decisive Move
The next decisive market move rarely waits. Equip yourself and take advantage of current opportunities.
30-Day Free Trial
We are so confident that The Arora Report will help you generate up to $5,000,000 more in lifetime wealth compared to any other resource that we are offering a completely free 30-day trial.
Your trial includes full access to over a decade of date stamped archives, so you can verify for yourself how well you would have done had you been a member earlier. We are confident you will conclude that with the help of The Arora Report, your performance would have been many, many times better than the major indexes.
Please click on the link below to start your free 30-day trial to ZYX Allocation Alert.
Please click here to take advantage of a FREE 30 day trial.
Your credit card is not charged during the trial. If you choose, you can cancel during the trial period and owe nothing.
Markets can generate substantial wealth for knowledgeable investors. NOW YOU TOO CAN ALSO SPECTACULARLY SUCCEED AT MEETING YOUR GOALS WITH THE HELP OF THE ARORA REPORT. You are receiving less than 1% of the content from our paid services. …TO RECEIVE REMAINING 99%, INCLUDING MANY ATTRACTIVE INVESTMENT OPPORTUNITIES AND SIGNALS IN REAL TIME, TAKE A FREE
TRIAL TO PAID SERVICES.
The Arora Report is one of the only major global investment newsletters that does not employ a single salesperson—because it does not need to. While competitors rely on high-pressure sales tactics, The Arora Report grows purely through results, with satisfied members recommending it to their family and friends.
Join the service that investors trust the most and recommend to family and friends.
Please click here to take advantage of a FREE 30 day trial.
Nigam Arora
Nigam Arora is known for his accurate stock market calls. Nigam is a distinguished master of the macro. He is a popular columnist with over 100 million page views, an engineer, and nuclear physicist by background. Nigam has founded two Inc. 500 fastest growing companies and has been involved in over 50 entrepreneurial ventures. He is the developer of Theory ZYX of Successful Change Management and is the author of the book on Theory ZYX, as well as the developer of the ZYX Change Method for Investing.
Dr. Natasha Arora
Dr. Natasha Arora has significant expertise in investment analysis especially biotech, healthcare, and technology. Natasha is a graduate of Harvard Medical School followed by a postdoc at MIT. She has published several peer reviewed research papers in top science journals.
